300119.SZ
瑞普生物
SZSE · Healthcare · C 制造业 · CN
CNY 17.34
−3.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 19.06x
- P/E 2027E
- 15.68x
- P/E 2028E
- 12.76x
- P/S forward
- 8.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- 20.12x
- PEG TTM
- 3.67x
- Price / book
- 1.74x
- Price / sales
- 2.42x
- Price / cash flow
- 34.93x
Enterprise value
- Enterprise value
- CNY 9.3B
- EV / sales
- 2.74x
- EV / EBITDA
- 13.49x
- EV / EBIT
- 19.83x
- Market cap
- CNY 8.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026